Analysis of real-time PCR and IHC staining on tissue microarray specimens revealed that higher CCR2 expression was also associated with higher Gleason score and higher clinical pathologic stages [54], suggesting a positive association between CCR2 expression and prostate cancer progression [54]. The gene discussed is CCR2; the disease is Familial prostate cancer.